Faculty who have authored publication Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.
Name | Title | Department | Institution |
---|---|---|---|
Ehab L. Atallah MD | Professor | Medicine | Medical College of Wisconsin |